These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39059349)

  • 1. Insights into the mechanisms of angiogenesis in infantile hemangioma.
    Xiang S; Gong X; Qiu T; Zhou J; Yang K; Lan Y; Zhang Z; Ji Y
    Biomed Pharmacother; 2024 Sep; 178():117181. PubMed ID: 39059349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
    Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
    Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
    Pan WK; Li P; Guo ZT; Huang Q; Gao Y
    Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol.
    Rotter A; de Oliveira ZNP
    J Dtsch Dermatol Ges; 2017 Dec; 15(12):1185-1190. PubMed ID: 29193649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.
    Greenberger S; Bischoff J
    Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a006460. PubMed ID: 22229118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Infantile Hemangioma a Neuroendocrine Tumor?
    Kaulanjan-Checkmodine P; Oucherif S; Prey S; Gontier E; Lacomme S; Loot M; Miljkovic-Licina M; Cario M; Léauté-Labrèze C; Taieb A; Moisan F; Rezvani HR
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.
    Zhang L; Mai HM; Zheng J; Zheng JW; Wang YA; Qin ZP; Li KL
    Int J Clin Exp Pathol; 2014; 7(1):48-55. PubMed ID: 24427325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
    Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
    Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
    Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
    J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
    Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
    Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Thrombospondin-1 and Nuclear Factor-κB Signaling Pathways in Antiangiogenesis of Infantile Hemangioma.
    Xu W; Li S; Yu F; Zhang Y; Yang X; An W; Wang W; Sun C
    Plast Reconstr Surg; 2018 Sep; 142(3):310e-321e. PubMed ID: 30148773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of connexins in infantile hemangiomas.
    Blanke K; Dähnert I; Salameh A
    Front Pharmacol; 2013; 4():41. PubMed ID: 23596415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade.
    Moisan F; Oucherif S; Kaulanjan-Checkmodine P; Prey S; Rousseau B; Bonneu M; Claverol S; Gontier E; Lacomme S; Dousset L; Couffinhal T; Toutain J; Loot M; Cario-André M; Jullié ML; Léauté-Labrèze C; Taieb A; Rezvani HR
    Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33558238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-elemene affects angiogenesis of infantile hemangioma by regulating angiotensin-converting enzyme 2 and hypoxia-inducible factor-1 alpha.
    Wang Z; Wang Z; Du C; Zhang Y; Tao B; Xian H
    J Nat Med; 2021 Jun; 75(3):655-663. PubMed ID: 33861415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways in the development of infantile hemangioma.
    Ji Y; Chen S; Li K; Li L; Xu C; Xiang B
    J Hematol Oncol; 2014 Jan; 7():13. PubMed ID: 24479731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment.
    Wnęk A; Andrzejewska E; Kobos J; Taran K; Przewratil P
    Immunol Lett; 2017 May; 185():27-31. PubMed ID: 28279700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transcription factor is the target of propranolol treatment in infantile hemangioma.
    Schrenk S; Boscolo E
    J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 35104803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.
    Mong EF; Akat KM; Canfield J; Lockhart J; VanWye J; Matar A; Tsibris JCM; Wu JK; Tuschl T; Totary-Jain H
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1321-1332. PubMed ID: 29724816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.
    Storch CH; Hoeger PH
    Br J Dermatol; 2010 Aug; 163(2):269-74. PubMed ID: 20456345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres.
    Zhu X; Guo X; Liu D; Gong Y; Sun J; Dong C
    Oncol Rep; 2018 Jan; 39(1):109-118. PubMed ID: 29192323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.